Moreover, we found that a high expression of RPS24 can predict a poor response to immunotherapy in HCC patients, which may not only be related to the regulation of immune cells and immune checkpoints but also be negatively related to the interferon-alpha/gamma signaling pathway [32]. Here, RPS24 is linked to hepatocellular carcinoma.